Document Detail


Remission of severe antiphospholipid syndrome associated with non-Hodgkin's B-cell lymphoma after combined treatment with rituximab and chemotherapy.
MedLine Citation:
PMID:  16266928     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The association of lymphoid neoplasms and antiphospolipid antibodies (APA), with or without thromboembolic complications, has been reported in several cases. We describe one case of B-cell non-Hodgkinís lymphoma (NHL) in which the combination of rituximab with standard chemotherapy led to the complete remission of a severe hypercoagulable state associated with APA.
Authors:
Dino Veneri; Achille Ambrosetti; Massimo Franchini; Federico Mosna; Giovanni Poli; Giovanni Pizzolo
Related Documents :
20976208 - The spectrum of coincident entities with small lymphocytic lymphoma/chronic lymphocytic...
15160968 - Primary burkitt's lymphoma only involving the chest wall at relapse in a child.
7089478 - Non-tropical idiopathic splenomegaly (dacie's syndrome): report of 5 cases.
11697448 - Asbestos exposure and malignant lymphomas--a review of the epidemiological literature.
20141878 - Fragrance material review on methylheptenol.
9336678 - An analysis of morning report at a pediatric hospital.
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  Haematologica     Volume:  90 Suppl     ISSN:  1592-8721     ISO Abbreviation:  Haematologica     Publication Date:  2005 Nov 
Date Detail:
Created Date:  2005-11-03     Completed Date:  2006-06-12     Revised Date:  2014-08-25    
Medline Journal Info:
Nlm Unique ID:  0417435     Medline TA:  Haematologica     Country:  Italy    
Other Details:
Languages:  eng     Pagination:  ECR37     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Antibodies, Monoclonal / therapeutic use*
Antibodies, Monoclonal, Murine-Derived
Anticoagulants / therapeutic use
Antineoplastic Combined Chemotherapy Protocols / administration & dosage,  therapeutic use*
Antiphospholipid Syndrome / etiology*
Combined Modality Therapy
Cyclophosphamide / administration & dosage
Doxorubicin / administration & dosage
Heparin / therapeutic use
Humans
Immunotherapy*
Lymphoma, B-Cell / complications,  drug therapy*,  immunology,  surgery
Male
Middle Aged
Prednisone / administration & dosage
Pulmonary Embolism / drug therapy,  etiology
Recurrence
Remission Induction
Splenectomy
Thrombophilia / drug therapy,  etiology*
Thrombophlebitis / drug therapy,  etiology
Vincristine / administration & dosage
Warfarin / therapeutic use
Chemical
Reg. No./Substance:
0/Antibodies, Monoclonal; 0/Antibodies, Monoclonal, Murine-Derived; 0/Anticoagulants; 0/rituximab; 57-22-7/Vincristine; 5Q7ZVV76EI/Warfarin; 80168379AG/Doxorubicin; 8N3DW7272P/Cyclophosphamide; 9005-49-6/Heparin; VB0R961HZT/Prednisone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Human herpesvirus 8 and Epstein-Barr virus coinfection in localized Castleman disease during pregnan...
Next Document:  Premature labor and leukoerythroblastosis in a newborn with parvovirus B19 infection.